CRO support for ncats medicinal chemistry for lead optimization.

Ended Awarded Last action

Contract number
75N95019D00031
Awardee
Awarding agency
Task orders
3 $4,673,542 obligated

Award facts

Opportunity
Combined order value
  • $4,673,542 Current, with exercised options
  • $6,068,898 Potential, with all options
Last date to order 100% complete
IDV ceiling 26% used
$17,887,012.00
Maximum order
$17,887,012.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 13 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The federal contract IDV award is a Cooperative Research and Development Agreement (CRDA) Support contract for the National Center for Advancing Translational Sciences (NCATS) Medicinal Chemistry for Lead Optimization program. The prime contractor, the Regents of the University of Minnesota, dba the Office of Sponsored Projects Administration, has been awarded multiple delivery orders under this IDIQ contract to provide synthetic chemistry support, lead optimization research, and drug discovery services to NCATS, a component of the National Institutes of Health (NIH).

The total ceiling value of the IDIQ contract is $17,887,012.00, with the University of Minnesota awarded delivery orders valued at $1,688,646.00, $2,790,714.00, and $1,725,318.18 to date. The contracted work is being performed at the University's facilities in Minneapolis, Minnesota, and involves supporting NCATS' efforts to develop new medications for substance use disorder and other translational research initiatives. The contract does not have any set-aside designations, reflecting the University of Minnesota's status as a prominent non-profit research institution with extensive experience executing federal research contracts and grants across diverse scientific domains.

Task orders

Transactions

Action Obligated Date
Terminate for Convenience P00002 · EOI:: implementing the presidents department of government efficiency cost efficiency initiative (march 19, 2025)::EOI notice of termination for convenience CRO… $0
Supplemental Agreement for work within scope P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N95019D00031?

75N95019D00031 was awarded to Regents Of The University Of Minnesota by National Institute on Drug Abuse (National Institutes of Health) on September 26, 2019.

How much is contract 75N95019D00031 worth?

Orders under 75N95019D00031 have obligated $4,673,542. Their combined potential value, with all options, is $6,068,898. 75N95019D00031's own ceiling is $17,887,012. A single order can be worth up to $17,887,012.

How many orders have been placed under contract 75N95019D00031?

3 orders have been placed under 75N95019D00031, the latest on September 28, 2022.

Which agency awarded contract 75N95019D00031?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019D00031, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Who can order from contract 75N95019D00031?

75N95019D00031 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N95019D00031 part of a contract vehicle?

Yes. 75N95019D00031 is part of CRO Support for NCATS Medicinal Chemistry for Lead Optimization.

Was contract 75N95019D00031 competed?

The extent of competition for 75N95019D00031 was full and open competition. The government received 13 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV